Trial Profile
Vytorin [Ezetimibe/simvastatin] as strategy to reduce dislipidemia in adults
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Dyslipidaemias
- Focus Registrational; Therapeutic Use
- Sponsors Organon
- 23 Apr 2008 New trial record.